Amarin Corporation plc (AMRN)
AMRN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$11.58
+0.43% on the day
Market cap
$244.6M
Micro cap
Revenue · 2025
$213.6M
-6.5% on 2024
Net income · 2025
-$38.8M
-18.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AMRN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Ireland |
| IPO year | Not reported by the screener |
| SEC CIK | 0000897448 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | X0 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $213.6M |
| Net income | -$38.8M |
| Operating income | -$50.2M |
| Net margin | -18.2% |
| Operating margin | -23.5% |
| Revenue growth | -6.5% |
| Cash | $134.7M |
| Total assets | $670.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2023-08-02 |
| Latest annual report | 10-K | 2026-03-02 |
| Latest quarterly / interim | 10-Q | 2026-07-29 |
| Latest current report | 8-K | 2026-07-29 |
| Latest proxy | DEF 14A | 2026-04-10 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ACIU | AC Immune SA | $2.40 | -2.04% | $244.3M |
| LFCR | Lifecore Biomedical Inc. | $6.42 | -0.31% | $243.0M |
| VOGX | Vogenx Inc | $16.76 | -2.22% | $249.0M |
| QTTB | Q32 Bio Inc. | $8.06 | -7.78% | $239.9M |
| RCKT | Rocket Pharmaceuticals Inc. | $2.30 | -7.26% | $252.5M |
| BBOT | BridgeBio Oncology Therapeutics Inc. Common Stock | $2.95 | -9.51% | $236.5M |
| BCYC | Bicycle Therapeutics plc | $3.63 | -4.47% | $254.1M |
| BIOA | BioAge Labs Inc. | $5.57 | -6.23% | $255.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier